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INTRODUCTION: Combining the hemodynamic and immune benefits of hypertonic saline with the anti-inflammatory effects of 
the phosphodiesterase inhibitor pentoxifylline (HSPTX) as a hemorrhagic shock resuscitation strategy reduces lung injury when 
compared with the effects of Ringer’s lactate (RL). We hypothesized that HSPTX exerts its anti-inflammatory effects by interfering 
with nuclear factor kappa B/cAMP response element-binding protein (NF-κB-CREB) competition for the coactivator CREB-binding 
protein (CBP) in lung tissue, thus affecting pro-inflammatory mediator production. 
METHODS: Male Sprague-Dawley rats underwent 60 minutes of hemorrhagic shock to reach a mean arterial blood pressure of 
35 mmHg followed by resuscitation with either RL or HSPTX (7.5% HS + 25 mg/kg PTX). After four hours, lung samples were 
collected. NF-κB activation was assessed by measuring the levels of phosphorylated cytoplasmic inhibitor of kappa B (I-κB) and 
nuclear NF-κB p65 by western blot. NF-κB and CREB DNA-binding activity were measured by electrophoretic mobility shift assay 
(EMSA). Competition between NF-κB and CREB for the coactivator CBP was determined by immunoprecipitation. Interleukin-8 
(IL-8) levels in the lung were measured by ELISA. 
RESULTS: RL resuscitation produced significantly higher levels of lung IL-8 levels, I-κB phosphorylation, p65 phosphorylation, 
and NF-κB DNA binding compared with HSPTX. NF-kB-CBP-binding activity was similar in both groups, whereas CREB-CBP-
binding activity was significantly increased with HSPTX. CREB-DNA binding-activity increased to a greater level with HSPTX 
compared with RL. 
DISCUSSION: HSPTX decreases lung inflammation following hemorrhagic shock compared with conventional resuscitation using 
RL through attenuation of NF-kB signaling and increased CREB-DNA binding activity. HSPTX may have therapeutic potential 
in the attenuation of ischemia-reperfusion injury observed after severe hemorrhagic shock.
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INTRODUCTION
Hemorrhagic shock is a major cause of death during the 
initial phases of trauma. The duration of ischemia and the 
degree of reperfusion associated with hemorrhagic shock have 
been linked to the development of acute lung injury (ALI) 
and multi-system organ failure (MSOF). ALI and its most 
severe form, acute respiratory distress syndrome (ARDS), 
are characterized by disruption of the pulmonary endothelial 
barrier, which leads to interstitial edema, reduced lung 
compliance, and persistent hypoxia.1 The rapid production 
of chemokines and cytokines, including interleukin-8 
(IL-8), after an inflammatory insult such as hemorrhagic 
shock is preceded by and dependent on an increase in the 
corresponding mRNA transcripts and is a direct consequence 
of the initiation of pro-inflammatory gene transcription.2,3 
These particular genes have been shown to contain promoter 
regions that can bind transcriptional factors, including nuclear 
factor-kappa B (NF-κB) and cAMP response element-binding 
protein (CREB), and modulate gene transcription in a positive 
or negative manner.4 622
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Activity of the transcriptional factor NF-κB has been 
shown to correlate with the severity of illness in systemic 
inflammatory response syndrome (SIRS) patients and was 
significantly increased in nonsurvivors when compared 
with survivors of septic shock.5,6 In its inactive state, NF-κB, 
which is mainly composed of two subunits, p50 and p65, is 
retained in the cytoplasm and associated with the inhibitory 
protein, I-κB.7 In conditions such as ischemia-reperfusion 
and endotoxemia, I-κBα, the major cytosolic inhibitor of 
NF-κB, undergoes phosphorylation, ubiquitination, and 
subsequent proteolytic degradation by the 26S proteosome.8,9 
This process results in unmasking of the nuclear localization 
signal and translocation of p65 to the nucleus. Once in the 
nucleus, NF-κB can bind with high affinity to the promoter 
regions of pro-inflammatory genes such as tumor necrosis 
factor alpha (TNF-α), IL-1, IL-8, and intracellular adhesion 
molecule-1 (ICAM-1).
CREB is involved in cell proliferation, differentiation, 
and adaptive responses. Stimulus-induced activation 
of CREB can occur secondary to a variety of cellular 
stressors, including ischemia-reperfusion, and is mediated 
by phosphorylation of CREB at serine residue 133.10 The 
coactivator CREB-binding protein (CBP) and its paralogue 
p300 regulate transcription through selective interaction with 
individual transcription factors. The phosphorylated forms of 
both NF-κB and CREB have been demonstrated to bind to 
the same site in the N-terminal region of CBP (also called 
the KIX region).11 Given that CBP is present in the nucleus 
of cells in limiting amounts, competition between NF-κB 
and CREB for CBP may represent an additional transcription 
regulatory mechanism.
The current clinical resuscitation regimen in patients 
with hemorrhagic shock necessitates the administration 
of substantial volumes of Ringer’s lactate (RL). However, 
there is considerable evidence indicating that RL infusion 
enhances neutrophil activation and potentiates lung injury 
through upregulation of oxidative stress and expression of 
adhesion molecules.12-14 These findings have prompted the 
search for alternative resuscitation strategies. 
The utilization of Pentoxifylline (PTX) as an adjunct to 
RL infusion and the concept of low-volume resuscitative 
fluids such as hypertonic saline (HS) have been extensively 
studied. Both strategies are capable of reducing the end-
organ injury observed with RL through the attenuation of 
bacterial translocation, ICAM-1 expression, neutrophil 
sequestration, and oxidative bursts.15-19 
With this knowledge, our laboratory has proposed 
use of both HS and PTX (HSPTX) as a low-volume anti-
inflammatory resuscitative fluid. In an animal model of 
hemorrhagic shock, we previously showed that resuscitation 
with HSPTX resulted in the attenuation of pulmonary 
neutrophil infiltration, TNF-α levels, IL-1 expression, and 
histological ALI.20 In this series of experiments, we further 
investigated the mechanism by which HSPTX attenuates 
pulmonary inflammation. We hypothesized that HSPTX 
reduces lung injury through inhibition of the NF-κB cascade 
and alteration of CBP transcription factor coactivation, thus 
affecting pro-inflammatory mediator production.
 
METHODS AND MATERIALS
The experiment was approved by the University of 
California San Diego Animal Subjects Committee and is in 
accordance with the guidelines established by the National 
Institutes of Health.
Experimental Model
Male Sprague-Dawley rats (300-400 g) were purchased 
from Harlan Sprague-Dawley (San Diego, CA). A 12-
hour light/dark cycle was instituted, and food and water 
were provided ad libitum. Animals were anesthetized with 
ketamine and xylazine by intraperitoneal injection. A right 
inguinal incision was performed, and the femoral artery 
and vein were cannulated with polyethylene catheters 
(PE50). The venous catheter was utilized for injection of 
resuscitative fluids, and the arterial catheter was used to 
withdraw blood and monitor the mean arterial pressure 
(MAP). Blood was withdrawn over a period of up to 10 
minutes until a MAP of 35 mmHg was obtained. Controlled 
hypotension was maintained at 35+5 mmHg for 1 hour 
by withdrawal or reinfusion of blood as necessary. The 
body temperature of the animals was maintained at 37 °C 
throughout the experiment. 
At the end of the shock period, animals were randomly 
divided into three groups according to the treatment received. 
sham animals (n = 5) underwent cannulation without shock or 
resuscitation and served as negative controls. RL-resuscitated 
animals (n = 7) received 32 mL/kg of racemic RL. HSPTX-
treated animals (n = 7) received 4 mL/kg of 7.5% NaCl + 25 
mg/kg of PTX (Sigma, St. Louis, MO). 
The RL infusion volume was calculated to yield sodium 
loads equivalent to those in HSPTX-treated animals. 
The dose of PTX was chosen based on multiple studies 
from our laboratory demonstrating its safety and lack of 
hypotension.20 At the end of volume resuscitation, the 
catheters were removed, the incision was closed, and the 
animals were returned to their cages. The animals were 
sacrificed via cardiac puncture after completion of shock 
and resuscitation, which included the one hour duration 
of hemorrhagic shock and the four hours following 
resuscitation. 623
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Lung Procurement and Extraction of Nuclear and 
Cytoplasmic Proteins
After a median sternotomy, the right lung of each 
animal was excised and snap-frozen in liquid nitrogen. 
Lung tissue samples weighing approximately 100 mg were 
homogenized using a dounce homogenizer. Nuclear and 
cytoplasmic proteins from the lung tissue were isolated with 
NE-PER™ nuclear and cytoplasmic extraction reagents 
supplemented with 1x Halt protease inhibitor cocktail per 
the manufacturer’s instructions (Pierce, Rockland, IL). The 
total protein concentration of each extract was determined 
using the bicinchoninic acid protein assay according to a 
microplate procedure (Pierce). Absorbance was measured 
and a standard curve for albumin was generated at 562 nm 
using a microplate reader (Molecular Devices, Sunnyvale, 
CA). Extracts were then aliquoted and stored at -70 °C until 
they were used in subsequent experiments.
NF-kB and I-kB Western Blot Analysis
To determine the degree of I-κB dissociation from 
NF-κB, we measured the amount of phosphorylated I-κB 
in cytoplasmic extracts. In addition, nuclear extracts were 
used to determine the degree of NF-κB phosphorylation 
and translocation. In separate experiments, cytoplasmic 
and nuclear extracts (10 mg of protein) were separated by 
sodium dodecyl sulfate (SDS)-polyacrylamide gradient gel 
electrophoresis and transferred to nitrocellulose membranes. 
The membranes were blocked with blocking solution, 
which was composed of 5% milk (Sigma) prepared in Tris-
buffered saline/Tween 20 (Fischer Scientific, Pittsburgh, 
PA), for 1 hour and incubated with phosphorylated I-κBα 
antibody (1:200 dilution; Cell Signaling, Beverly, MA) or 
phosphorylated NF-κB antibody (1:500; Cell Signaling), 
respectively, overnight at 4 °C. The membranes were 
washed with Tris-buffered saline/Tween 20 and incubated 
for 1 hour at room temperature with the secondary 
antibody, horseradish peroxidase-linked anti-rabbit IgG 
(Cell Signaling), which was prepared in blocking solution 
(1:2000). After washing, the membrane was processed with 
the Pierce Supersignal West Pico Chemiluminescent Kit and 
exposed to X-ray film (Hyperfilm, Amersham Pharmacia, 
Piscataway, NJ) to permit detection of the antibody 
complexes.
NF-kB and CREB Electrophoretic Mobility Shift Assay
The nonradioactive LightShift Chemiluminescent 
Electrophoretic Mobility Shift Assay (EMSA) Kit was 
used to detect DNA-transcription factor interactions. The 
3’ biotin end-labeled oligonucleotide used as a probe 
for the NF-κB EMSA was a 42-bp double-stranded 
oligonucleotide (5’-TTGTTACAAGGGGACTTTCCGCTG 
GGGACTTTCCGGGAGGC-3’) containing two tandomly 
repeated NF-κB binding sites (underlined). The 3’ 
biotin end-labeled oligonucleotide used in the CREB 
EMSA was a 23-bp double-stranded oligonucleotide 
(5’-TTTTCGAGCTCTGACGTCAGAGC-3’). Specificity 
for each experiment was determined by a competition assay 
in which 200 M excess of unlabeled double-stranded NF-
κB or CREB oligonucleotide was included in the respective 
reaction mixture. 
Nuclear extracts (10 mg) were incubated with 5 nM 
NF-κB or CREB probe (1× binding buffer, 150 mmol/L 
KCl, 0.1 mmol/L EDTA, 2.5 mmol/L DTT, 0.05% NP40, 
10% glycerol, and 50 ng/mL poly[dI-dC]) and subjected 
to electrophoresis through a 6% DNA retardation gel at 
100 V for 90 minutes. Nucleic acid was electrophoretically 
transferred from the gel to a positively charged nylon 
membrane (Roche Applied Science, Indianapolis, IN) at 
380 mA for 1 hour on ice and immediately UV cross-linked 
for 15 minutes using a UV transilluminator equipped with a 
312-nm bulb. Streptavidin-horseradish peroxidase conjugate 
and the LightShift Chemiluminescent Substrate were used 
in a chemical reaction to detect the biotin end-labeled 
oligonucleotide. The nylon membranes were exposed to 
X-ray film for 1-3 minutes to permit detection.
CBP Immunoprecipitation
Interactions between CBP and CREB or p65 were 
demonstrated with a modification of the method reported 
by Gerritsen and coworkers.21 Lung nuclear extracts (10 
mg) were suspended in 0.5 M phosphate lysis buffer (pH 
8) in Eppendorf tubes (Fischer Scientific) and rotated 
for 20 minutes at room temperature with an anti-CBP 
antibody (A22) (Santa Cruz Biotechnology, Santa Cruz, 
CA) cross-linked to protein A magnetic beads according 
to the manufacturer’s protocol (Invitrogen, Carlsbad, 
CA). The beads were washed twice with phosphate lysis 
buffer and eluted into SDS sample buffer (Invitrogen) by 
boiling for 5 minutes. The samples were then submitted 
to electrophoresis through SDS-polyacrylamide gels and 
transfer to nitrocellulose membranes. The membranes were 
blocked with 5% milk prepared in Tris-buffered saline/
Tween 20 for 1 hour and incubated overnight at 4 °C with 
anti-CBP (C1) (1:1000), anti-p65 NF-κB (1:400) and anti-
CREB (1:1000). Washing, secondary antibody incubation, 
and antibody-complex detection were performed as 
described above in the western blot section. 624
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Interleukin-8 Content Determination
The concentration of IL-8 in the lung was quantitatively 
measured from bronchoalveolar lavage fluid (BALF) using 
ELISA. Immediately after animal sacrifice, the trachea 
was accessed via a tracheotomy. Ten ml of normal saline 
was instilled under direct vision of the lung to avoid 
overdistension. BALF was collected and centrifuged at 250 g 
for 10 minutes. Similar amounts of BALF were obtained for 
each animal. Anti-CINC antibodies were utilized to detect 
rat IL-8 (Peptide Institute, Osaka, Japan). The wells of a 
96-well immunoplate (NUNC Brand, Rochester, NY) were 
coated with the capture antibody, goat anti-CINC antibody 
diluted 1:396 in coating buffer, and incubated overnight at 
4 °C. Nonspecific binding sites were blocked with a buffer 
composed of 5% milk in sterile PBS (Irvine Scientific, 
Santa Ana, CA). The wells of the plate were washed with 
0.05% Tween 20 in PBS. Undiluted BALF was incubated 
on the plate at room temperature for 2 hours along with IL-8 
standard (Peptide Institute) diluted to the range of 0-25 ng/
mL in blocking buffer for standard curve generation. After 
washing, the secondary antibody abbit anti-CINC IgG was 
diluted to 1:2000 in blocking buffer and dispensed onto the 
plate for incubation at room temperature. The horseradish 
peroxidase-linked goat anti-rabbit conjugate (Cell Signaling) 
was instilled on the plate and incubated at room temperature 
for 30 minutes. An Immunopure TMB Substrate Kit 
(Pierce) was used for detection. The reaction was stopped 
by the addition of a final concentration of 2M H2SO4 after 
15 minutes, and absorbance was measured at 450 nm. 
Measurements for each animal were performed in duplicate.
Statistical Analysis
Data are presented as the mean percentage of RL 
stimulation +/- the standard error of the mean (SEM). 
Assays were performed in duplicate when appropriate. 
The percentage of RL stimulation was calculated by 
dividing each sample mean by the mean of RL stimulation 
and multiplying the number by 100. A one-way analysis 
of variance (ANOVA) was used to test for significant 
differences between experimental groups. Statistical 
significance was defined as a p value < 0.05. 
RESULTS
Cytoplasmic I-kB Phosphorylation
We  assessed  changes  in  cytoplasmic  I-κBα 
phosphorylation as this is a proximal step in the activation 
and nuclear translocation of NF-κB. Resuscitation with RL 
led to a fivefold increase in I-κBα phosphorylation compared 
with the level detected in sham treated animals (Figure 
1). HSPTX infusion resulted in a 63% reduction in I-κBα 
phosphorylation when compared with RL treatment (100 vs. 
37 + 21; p = 0.043). 
Nuclear NF-kB Phosphorylation
To assess whether the attenuation I-κBα phosphorylation 
observed with HSPTX after hemorrhagic shock affected 
nuclear translocation of NF-κB, we analyzed the relative 
amounts of phosphorylated p65 NF-κB in lung nuclear 
extracts. As expected, RL-treated animals had a higher 
degree of translocation over that of the sham group (Figure 
2). The HSPTX group demonstrated a 49% decline in NF-
κB nuclear transfer in comparison with their RL-treated 
counterparts (51 + 3 vs. 100; p < 0.01). 
NF-kB-DNA Binding Activity
The binding of NF-κB to specific DNA promoter regions 
results in the initiation of transcription and the induction 
of pro-inflammatory gene expression associated with 
reperfusion injury. The association of p65 NF-κB with DNA 
was roughly equivalent in the sham and HSPTX groups (54 
+5 vs. 30 + 19) (Figure 3). Post-shock resuscitation with RL 
produced a marked increase in binding over that of HSPTX 
(100 vs. 30 + 19; p = 0.01). These findings correlate with 
the relative degree of phosphorylated nuclear p65 NF-κB 
observed in the previous experiment. 
Figure 1 - Cytoplasmic I-κBα Phosphorylation. A, Representative western 
blot of phosphorylated cytoplasmic I-κBα at 4 hours after hemorrhagic shock 
and resuscitation. The image displays two representative animals from each 
experimental group. B, Histogram illustrating the 63% increase in phos-
phorylation of I-κBα when RL, rather than HSPTX, was administered after 
shock. The graph presents changes in the mean density for n = 5-7 animals 
per group. *, p < 0.043 vs. RL.625
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CBP Interactions with NF-kB and CREB
To determine whether coactivator affinity for the 
transcription factors associated with inflammation was 
affected by the type of fluid administered after hemorrhagic 
shock, we evaluated the relative increases in CBP binding 
to NF-κB and CREB after RL and HSPTX resuscitation. 
Both RL and HSPTX-treated animals had a similar degree 
of CBP-NF-κB binding activity (10.56% vs. 10.25%). 
Resuscitation with HSPTX resulted in a marked rise in 
the association between CBP and CREB when compared 
with RL treatment (24% vs. 4.34%) (Figure 4). These data 
indicate that RL given after hemorrhagic shock favors 
co-activation of NF-κB and subsequent pro-inflammatory 
mediator synthesis. With HSPTX resuscitation, the 
association between CREB and CBP outweighs that 
demonstrated with NF-κB.
CREB-DNA Binding Activity
Given that an increased association between CBP and 
CREB was evident with HSPTX, we sought to determine 
whether CREB-DNA binding was upregulated. HSPTX-
treated animals demonstrated a 93% increase in the 
association of CREB and DNA over their RL counterparts 
(193 + 11 vs. 100; p = 0.001) (Figure 5). Both sham and RL-
treated animals had similar levels of CREB DNA-binding 
activity (110 + 6 vs. 100). 
Interleukin-8 Concentration
Synthesis of the pro-inflammatory mediator IL-8 is partly 
influenced by activation of the transcription factor NF-κB. IL- 
Figure 2 - Nuclear p65 NF-κB Phosphorylation. A, Western blot of phos-
phorylated p65 NF-κB in pulmonary nuclear extracts after hemorrhagic shock 
and resuscitation. The image displays two representative animals from each 
experimental group. B, RL infusion markedly enhanced nuclear NF-κB phos-
phorylation. A 49% attenuation in nuclear p65 phosphorylation was seen when 
HSPTX was utilized for treatment after shock. The graph presents changes 
in the mean pixel density for n = 5-7 animals per group. *, p < 0.01 vs. RL
Figure 3 - NF-κB-DNA Binding Activity after Hemorrhagic Shock and 
Resuscitation. A, Representative EMSA illustrating NF-κB binding to DNA 
at 4 hours after post-shock resuscitation. The image displays two representa-
tive animals from each experimental group. B, Histogram demonstrating the 
marked upregulation of NF-κB-DNA binding activity associated with RL treat-
ment. The graph presents changes in mean pixel density for n = 5-7 animals 
per group. HSPTX treatment attenuated this response by 70% and resulted in 
binding levels similar to those detected in the sham group. *, p = 0.01 vs. RL.
Figure 4 - Alterations in CBP Binding Activity After Resuscitation. A, 
Representative immunoprecipitation blot of animals resuscitated with either 
RL (1) or HSPTX (2). The image displays two representative animals from 
each experimental group. B, Graph demonstrating the percent increases 
in NF-κB and CREB CBP-binding activity after resuscitation with RL or 
HSPTX. Treatment with RL resulted in a greater proportion of NF-κB co-
activation, while CBP-CREB binding activity was shown to predominate 
with HSPTX treatment. The graph presents changes in mean pixel density 
for n = 5-7 animals per group.626
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8 regulates chemotaxis, directional neutrophil migration, and 
neutrophil activation in the lung during ischemia-reperfusion 
injury. Resuscitation with RL caused a significant increase in 
the BALF IL-8 concentration at 4 hours compared with sham 
animals (100% vs. 38% + 6; p < 0.0001) (Figure 6). HSPTX 
resuscitation led to a 55% decrease in IL-8 levels when 
compared with their RL counterparts (45% + 9 vs. 100; p < 
0.0001). This reduction in cytokine expression correlates with 
the decline in NF-κB activity, coactivation, and DNA binding 
activity observed with HSPTX.
DISCUSSION
Hemorrhagic shock is the most prominent cause of 
patient morbidity and mortality after severe trauma. In 
contrast to those who die early as a result of uncontrolled 
bleeding, patients who survive the initial period of shock 
and resuscitation may develop an uncontrolled systemic 
inflammatory response that culminates with end-organ 
injury. Cytokines and reactive oxygen species produced 
during the reperfusion period are responsible for neutrophil 
and monocyte/macrophage activation, which, if unregulated, 
results in the development of ALI and ARDS.22 
PTX, a methylxanthine derivative and nonspecific 
phosphodiesterase inhibitor, has classically been used 
for the treatment of intermittent claudication due to its 
hemorheologic properties.23 More recently, PTX has been 
shown to yield beneficial effects on the inflammatory 
cascade by increasing cAMP and subsequently reducing 
TNF-α levels.24 Our laboratory and others have extensively 
studied PTX as an immunomodulator in hemorrhagic 
shock. In animal models, the administration of PTX after 
hemorrhage improves tissue oxygenation, intestinal blood 
flow, and animal survival.25-27 PTX alone is not a volume 
expander and cannot be used as the sole treatment for shock. 
Therefore, it must be given as an adjunct therapy with the 
appropriate volume resuscitation. 
The concept of small-volume resuscitation consisting of 
4 mL/kg of 7.5% NaCl (HS) in the setting of hemorrhagic 
shock has been a topic of recent research. HS not only offers 
the advantages of more rapid administration and almost 
instantaneous hemodynamic stability, it also downregulates 
neutrophil activation and organ injury in comparison with 
RL.14-16,18 With these findings in mind, our laboratory 
has utilized HSPTX as a combined fluid for post-shock 
resuscitation and has demonstrated a reduction in end-
organ injury and pro-inflammatory mediator production 
in comparison with RL.19 We have previously shown that 
treatment with HSPTX decreases histological lung injury 
using an animal model of hemorrhagic shock.20 In this 
series of experiments, we further investigated the effects of 
resuscitation with HSPTX on pulmonary inflammation in an 
animal model of hemorrhagic shock.
In this study, we chose to study changes in lung 
inflammation at the 4-hour time point based on our 
previous studies using this animal model of hemorrhagic 
shock. HSPTX infusion resulted in a significant reduction 
in pulmonary IL-8 levels when compared with RL 
administration. Molecular studies examining IL-8 gene 
activation have shown that the majority of IL-8 gene 
transcription is mediated by activation of NF-κB and 
that inhibition of NF-κB expressionusing antisense 
oligonucleotide inhibits IL-8 production in vitro8,29 
Therefore, the attenuation of IL-8 expression observed in 
this study is most likely due to downregulation of the NF-κB 
cascade induced by HSPTX therapy.
Figure 5 - CREB-DNA Binding Activity After Hemorrhagic Shock and 
Resuscitation. A, Representative EMSA illustrating CREB DNA-binding 
activity at 4 hours after post-shock resuscitation. The image displays two rep-
resentative animals from each experimental group. B, Histogram presenting 
changes in mean pixel density for n = 5-7 animals per group compared with 
RL-treated animals. Enhanced CREB-DNA binding activity was observed 
in animals receiving HSPTX infusion. RL-treated animals had CREB-DNA 
association levels similar to the sham group. *, p = 0.001 vs. RL.
Figure 6 - Resuscitation-induced Lung Interleukin-8 Levels. Animals resus-
citated with RL had increased concentrations of IL-8 in the lung. Resuscita-
tion with HSPTX led to a 55% attenuation of IL-8. The graph presents mean 
BALF IL-8 levels of all animals studied in each group. *, p < 0.0001 vs. RL. 627
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One of the key steps involved in NF-κB activation is 
phosphorylation of the inhibitory protein I-κBα, which 
allows for subsequent I-κB degradation and NF-κB 
activation.30 In vivo inhibition of I-κBα degradation has 
been shown to suppress lung inflammation in septic rats.31 
In this study, we observed marked attenuation in I-κBα 
phosphorylation in animals resuscitated with HSPTX after 
hemorrhagic shock, indicating a mechanism by which 
HSPTX exerts its anti-inflammatory effects. 
Multiple studies have demonstrated that agents that 
increase cAMP, such as PTX, cause activation of protein 
kinase A (PKA) and lead to inhibition of NF-κB-dependent 
pro-inflammatory gene expression.32-34 Haddad et al. 
reported results that are consistent with our study, showing 
the effects of PTX on I-κB and NF-κB in pulmonary 
epithelial cells.35 For NF-κB to recruit the transcriptional 
apparatus and stimulate gene expression, it must first 
undergo nuclear translocation and p65 subunit modification. 
Once in the nucleus, the p65 subunit is phosphorylated at 
serine 276, which enhances its ability to recruit CBP and 
p300 and subsequently bind to DNA.36,37 Here, HSPTX-
resuscitated animals displayed a marked reduction in 
nuclear phosphorylated NF-κB and NF-κB-DNA binding 
activity when compared with their RL-treated counterparts. 
Therefore, the attenuation of NF-κB activity exhibited 
with HSPTX is a consequence of the inhibition of 
phosphorylation of both I-κB in the cytoplasm and p65 in 
the nucleus.
In contrast to NF-κB, CREB-DNA binding activity was 
significantly upregulated when HSPTX was utilized for 
post-shock resuscitation. Phosphorylation of CREB at serine 
133 is primarily the result of a Protein Kinase A (PKA)-
dependent mechanism and is required for CREB activation.10 
Therefore, the elevation in cAMP that occurs with HSPTX 
resuscitation downregulates NF-κB expression while 
increasing the activity of the anti-inflammatory transcription 
factor CREB, thus modulating pro-inflammatory mediator 
synthesis and reducing lung inflammation. This concept is 
supported by our previous studies demonstrating attenuation 
of TNF-α synthesis with HSPTX both in vitro and in vivo20,38
Given that the interaction between both CREB and NF-
κB occurs through the same region of CBP (the KIX region), 
the competition between transcription factors for a finite 
amount of coactivator has the potential to be an additional 
transcription regulatory mechanism.21,39 In this study, the 
association between CBP and NF-κB predominated with 
standard RL resuscitation. In contrast, CREB-CBP binding 
was favored with HSPTX resuscitation, potentially accounting 
for the difference in pro-inflammatory mediator synthesis 
observed with different resuscitation modalities. These 
data are supported by the findings of Shenkar et al., who 
similarly demonstrated that inhibition of xanthine oxidase 
and production of reactive oxygen species in mice before 
hemorrhage reduced interactions between p65 and CBP, while 
CREB-CBP associations were significantly increased.11
We did not choose to use an HS-only control group, 
which may be viewed as a limitation of this study. We and 
others have extensively studied the immunomodulatory 
effects of hypertonic saline alone. The goal of this study was 
to combine a small-volume immunomodulatory resuscitation 
fluid (HS) with an anti-inflammatory drug (PTX). This 
strategy combines anti-inflammatory strategies and provides 
a vehicle for the delivery of PTX. The benefits of this 
combination in a small volume of fluid could be ideal for 
pre-hospital fluid therapy or resuscitation in the field. 
CONCLUSION
The use of HSPTX for fluid resuscitation after 
hemorrhagic shock may reduce the incidence of lung 
inflammation through attenuation of I-κB phosphorylation, 
NF-κB p65 nuclear translocation, CBP coactivation, 
and NF-κB-DNA binding activity. These alterations, 
coupled with increased CREB activity, led to diminished 
pro-inflammatory mediator production, which may have 
contributed to a decrease in tissue injury when compared 
with RL, the current standard resuscitation fluid. Therefore, 
this novel resuscitation strategy may have therapeutic 
potential in the attenuation of ischemia-reperfusion injury 
observed after severe hemorrhagic shock.
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